Home Virios Therapeutics

Virios Therapeutics

Most Read

New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series

FMW Media Work announces that its "New to The Street Leadership," Powered by Sector SPDR ETFs, will air on Bloomberg TV as sponsored programming on Saturday, February...

New to the Street 556 | Fox Business, Monday, February 19, 2024

1). Biopharmaceutical - Tonix Pharmaceuticals, Inc.'s (NASDAQ: TNXP) ($TNXP) interview with Dr. Seth Lederman, MD, Chairman and CEO. 2). Biopharmaceutical - Acurx Pharmaceuticals, Inc.'s (NASDAQ: ACXP) ($ACXP) interview with David Luci,...

Biopharmaceutical – Tonix Pharmaceuticals, Inc.’s (NASDAQ: TNXP) ($TNXP) interview with Dr. Seth Lederman, MD, Chairman and CEO.

From the Nasdaq MarketSite Studio, Dr. Seth Lederman, MD, Chairman and CEO of Tonix Pharmaceuticals, Inc. (NASDAQ: TNXP) ($TNXP) ("Tonix"), talks with New to The Street's TV Host Jane...

Decentralized Supercomputing – Dynex’s (CRYPTO: DNX) ($DNX) interview with Clifford Mapp, an Independent Expert and Blockchain Pioneer.

New to The Street's TV Host Jane King interviews Clifford Mapp, an independent expert and blockchain pioneer, who talks about Dynex (CRYPTO: DNX) ($DNX). As a...